SKIN ATLAS · ACTIVE INGREDIENT · 4 MIN READ

Glycolic Acid + Madecassoside for Over-Treated Skin: Exfoliation as a Re-Barrier Trigger

Glycolic acid + madecassoside for over-treated skin means in cosmetics: the targeted combination of an alpha-hydroxy acid with the triterpene glycoside from Centella asiatica to gradually restore a skin barrier compromised by over-treatment through controlled exfoliation and simultaneous regeneration signals. The approach utilizes the skin's biochemical stimulus-response mechanism, where low-dose acid exposure activates endogenous barrier renewal instead of further destabilizing it.

Term and Origin

Glycolic acid (INCI: Glycolic Acid) is the smallest of the alpha-hydroxy acids (AHAs) and has been systematically investigated in dermatological peeling research since the early 1990s. Its low molecular mass of 76 g/mol enables relatively rapid penetration through the epidermis. Madecassoside, on the other hand, is a triterpene glycoside isolated from the dry extract of Centella asiatica (L.) Urban and has been known in Asian wound healing medicine for decades. The term "over-treated skin" — often referred to in the English-speaking professional community as over-treated skin or compromised barrier skin — describes a condition caused by the excessive use of active ingredients (retinol, acids, peeling enzyme formulas, mechanical exfoliation) and manifested by redness, flaking, tightness, and increased sensitivity.

The conceptual paradox of this approach — exfoliation on an already damaged barrier — has its scientific basis in the understanding that suboptimal, non-aggressive acid doses can stimulate epidermal keratinocytes to increase the production of lamellar lipid structures (ceramides, fatty acids, cholesterol). This mechanism, discussed in the literature as "barrier-repair priming," differs fundamentally from aggressive deep peeling. The concept of dual formulation — acid plus a calming agent — has been established in modern AHA research since the early 2010s, even if the term "Re-Barrier Trigger" itself is a pragmatic formulation term in applied cosmetic chemistry.

The historical context is relevant: The peeling wave of the 1990s and early 2000s left the professional community in a critical discussion about barrier damage caused by uncontrolled acid use. Chemical Peeling has been increasingly investigated in terms of concentrations and pH ranges that allow for a therapeutic effect without permanent damage. Madecassoside has entered the formulation repertoire more intensively as a standalone, isolated active ingredient (unlike raw Centella extract) since the 2010s.

Characteristics & Mechanism of Action

Glycolic acid works primarily by weakening the ionic bonds between corneocytes in the stratum corneum. At a formulation pH of 3.5–4.0 and concentrations between 5% and 10% — the recommended low-dose range for over-treated skin — it selectively dissolves the outermost layer of outdated, dysfunctional horn cells without destabilizing the living epidermis underneath. At the same time, there is evidence in the literature that glycolic acid modulates the expression of Aquaporin-3 (AQP3), thereby influencing transepidermal water distribution. It is important that the pH of the preparation is crucial for the intensity of the effect: formulations with a pH above 4.5 show significantly reduced exfoliation activity.

Madecassoside unfolds its mechanism on several levels. As a triterpene glycoside, it modulates TGF-β1 signaling pathways (Transforming Growth Factor beta 1), which has been associated with increased collagen synthesis in cell culture studies. However, its anti-inflammatory effect is more important in the context of over-treated skin: Madecassoside inhibits NF-κB-dependent inflammatory cascades and reduces the release of pro-inflammatory cytokines (IL-1β, TNF-α). This anti-inflammatory capacity creates the biochemical environment in which the mild stimulus response simultaneously triggered by glycolic acid does not escalate into cumulative inflammation, but is redirected into a constructive regeneration process.

The synergy therefore does not consist in an additive increase of both individual effects, but in a complementary functional architecture: Glycolic acid opens the renewal window, madecassoside keeps the inflammatory framework controlled. For formulation stability, it should be noted that madecassoside can show stability losses in acidic pH ranges (below 3.0), which is why the pH compromise range of 3.5–4.0 also plays a role in formulation technology. Further information on the barrier protection function can be found in the entry on beta-glucan barrier protection as well as in the analysis on Ceramides and the Skin Barrier.

Skincare Approach

For over-treated skin, the principle of the minimum effective dose applies. A glycolic acid-madecassoside combination should generally be limited to 2–3 applications per week until measurable barrier recovery is observed (typically based on a reduced TEWL value, if diagnostically captured). The layering logic — layering — is recommended as follows: A low-concentration AHA preparation is applied to cleansed, dry skin, followed by a madecassoside-containing soothing formulation after an application time of approx. 20 minutes, to minimize unwanted pH neutralization by subsequent products. Alternatively, combination formulas are available in which both active ingredients are combined in a pH-buffered system.

In the context of the Chronobiology of the Skin, the application time is relevant: Since glycolic acid can have a photosensitizing effect, evening application is preferable. Circadian Rhythms of Skin Regeneration also speak for a nighttime application, as epidermal cell division and DNA repair are increased in the late evening and early morning hours. In addition, consistent lipid barrier support with ceramide-containing products should be provided — the entry on Ceramides offers further guidance.

For skin that is in an active recovery process, it is also recommended to reconsider a short Double Cleansing protocol: A single, gentle cleansing step prevents additional lipid depletion caused by a second cleanser. Barrier resilience can be additionally supported by Ectoin-containing formulations, as Ectoin reduces osmotic stress on keratinocytes.

NATURFACTOR® aligns with the rhythm logic of the skin — the alternation between daytime barrier stabilization and nighttime regeneration. The Porcelain Skin Serum (Day Rhythm, 30 ml) integrates as a daytime care formulation Pullulan, two forms of hyaluronic acid, Kigelia extract with bioactive flavonoids, amino acid-based active ingredients, functional silk polypeptides, as well as licorice root extract — with the effect direction of moisture retention, barrier function, and skin structure. The Blue Crystal Drops (Night Rhythm, 30 ml) is a facial oil for the night that contains bioactive phytosterols, vitamin C, bisabolol, as well as essential oils from blue lotus and blue cornflower, with the effect direction of nighttime regeneration, antioxidant protection, and protective film. Glycolic acid and madecassoside are not contained in either of the two products; for the proper integration of these active ingredients into a structured day-night routine, NATURFACTOR® refers to the concept of chronobiological skin care. Both products are available in The Perfect Duo.

Realistic Expectations

The recovery of over-treated skin through the described combination approach is not a linear process. In clinical observation contexts, initial improvements in barrier function — measured by transepidermal water loss (TEWL) — are observed after 4–6 weeks of consistent, low-dose application. Visible changes such as reduced redness and reduced flaking can occur earlier or later individually, depending on the initial condition, genetic barrier variability (e.g., filaggrin polymorphisms), and simultaneously used products.

It is important to calibrate expectations: The approach does not aim for visible, short-term peeling effects — these would be counterproductive for over-treated skin. The improvement shows itself subtly: less tightness, less reactive redness to external stimuli, more stable moisture retention. Those who expect quick exfoliation results run the risk of increasing the dose and interrupting the recovery process. Individual variation is large: dry climate, heater air (cf. dual barrier attack in winter cold), and travel stress can significantly slow down the recovery rate.

Frequently Asked Questions

Can glycolic acid even be used safely on over-treated, reddened skin?

Yes, but exclusively in low concentrations (5–8%) and at a formulation pH of 3.5–4.0. For active skin lesions, open irritation, or diagnosed rosacea, consultation with a dermatologist is required before AHA preparations are reintegrated into the routine. The combination with a calming agent like madecassoside reduces the risk of a cumulative inflammatory reaction, but does not replace a medical assessment in cases of pronounced barrier failure.

Why is madecassoside better suited than pure Centella extract in this combination?

Madecassoside is an isolated triterpene glycoside with clearly defined purity and concentration, which enables reproducible formulation stability. Raw Centella extracts contain a variable spectrum of triterpenes (asiaticoside, asiatic acid, madecassic acid) with fluctuating ratios, which makes pharmacological predictability and compatibility with acidic systems difficult. For a directly buffered acidic pH context — as is the case with glycolic acid formulations — the isolated active ingredient is more stable and better characterized in its anti-inflammatory effect.

How long should one continue the glycolic acid-madecassoside combination routine before increasing the dose?

As a guideline, a period of at least 6–8 weeks with the initial low dose applies before considering a dose increase. The deciding factor is not a fixed period, but the clinical picture: Only when redness and tightness have completely subsided and the skin reacts stably to external stimuli (temperature, wind) is a gradual dose increase justifiable. The parallel introduction of other active ingredients (retinol, BHA) should be suspended during this period.

Conclusion

The combination of glycolic acid and madecassoside for over-treated skin illustrates a central principle of modern formulation science: effectiveness is not created by maximizing individual active ingredient doses, but through the biochemically coherent interconnection of complementary mechanisms. Glycolic acid — in its low-dose form — triggers a controlled renewal impulse; madecassoside secures this process through inflammation modulation. The result is not a spectacular peeling effect, but a gradually more stable, resilient barrier. Those who want to bring over-treated skin back into balance are well advised to consider patience as an active factor in itself — and to consistently align the routine with the regeneration rhythms of the skin, as described in the concept of chronobiological skin care.

1. Sharad J. (2013). Glycolic acid peel therapy — a current review. Clinical, Cosmetic and Investigational Dermatology, 6, 281–288.
2. Bylka W., Znajdek-Awiżeń P., Studzińska-Sroka E., Brzezińska M. (2013). Centella asiatica in cosmetology. Postepy Dermatologii i Alergologii, 30(1), 46–49.
3. Dréno B., Zuberbier T., Gelmetti C., Gontijo G., Marinovich M. (2019). Safety review of phenoxyethanol when used as a preservative in cosmetics. Journal of the European Academy of Dermatology and Venereology, 33(S7), 15–24.
4. Haftek M., Mac-Mary S., Le Bitoux M. A., Creidi P., Seité S., Rougier A., Humbert P. (2008). Clinical, biometric and structural evaluation of the long-term effects of a topical treatment with salicylic acid and glycolic acid on sun-damaged skin. International Journal of Cosmetic Science, 30(3), 187–196.
5. Ratz-Łyko A., Arct J., Pytkowska K. (2016). Moisturizing and anti-inflammatory properties of cosmetic formulations containing Centella asiatica extract. Indian Journal of Pharmaceutical Sciences, 78(1), 27–33.